2012
Press release in BioSpectrum Asia, Singapore, April 11, 2012. SG Austria acquires world-wide rights for in vivo production method for antibodies:
“Singapore based biotech company SG Austria, the leading living cell encapsulation company, has acquired all rights to a patent family claiming the secretion of antibodies and antibody-like molecules from encapsulated cells. The technology allows continuous, steady state, secretion of therapeutic antibodies from the implanted cells, thereby avoiding the typical peaks and troughs associated with more conventional antibody delivery systems and immunization schemes. The inventors demonstrated safe, long term antibody production after a single implantation of the beads in mouse models as well as the use of the technology in a therapeutic setting to protect against a lethal virus disease. In principle, the technology can be used to treat any virus induced disease for which neutralising antibodies can be generated such as hepatitis B, hepatitis C, human immunodeficiency virus (HIV), West Nile virus, the SARS causing coronavirus and new variants of influenza virus. In addition, the technology can be used to improve current monoclonal antibody therapies for cancer treatment such as Herceptin, Rituxan, Avastin, Erbitux and Mylotarg.”
2011
Interview with Dr Brian Salmons (CEO) and Dr John Dangerfield (COO) for the article ‘Cover Story: Singapore’ published in the leading Korean economy magazine “G.Economy21″, 2011, Vol. 117, Dec. 12th.
CLICK IMAGE TO ENLARGE: G.Economy.21 article. Singapore, Cover Story
Interview with Dr Brian Salmons, CEO, for the article ‘Stem cells will bring a paradigm shift in disease treatment’ published in BioSpectrum Asia Edition, May 27th
Interview with Dr Lilli Brandtner, Chief Scientist, in an article, ‘World Travel, Day 39′, in the Austrian daily, Kurier, January.
From left to right: CEO, Dr. Brian Salmons; Chief Scientist, Dr. Eva Maria Brandtner; COO, Dr. John Dangerfield
2010
Comments from Professor Walter H. Günzburg, Chairman, in an article on ‘Singapore: the glittering authoritarian metropolis’ in the Austrian daily, Die Presse; 6 November.
Interview with Professor Walter H. Günzburg, Chairman and Dr. Brian Salmons, President and Chief Executive Officer, in Genewired, the cutting-edge biotechnology, medical and life sciences portal for scientists, researchers, pharmaceuticals; 5 August.
